Nasal drug delivery specialist Kurve Technology announced that the US Department of Defense (DoD) has awarded the company a contract for testing a formulation for the treatment of traumatic brain injury (TBI).
The Kurve ViaNase device is an electronic atomizer based on a controlled particle dispersion technology platform making use of vortical flow that “effectively disrupts inherent nasal cavity airflows to deliver formulations to the entire nasal cavity,” the company says
According to Kurve, the company also has DoD contracts for development of intranasal therapies for post-traumatic stress disorder (PTSD), with one of its two PTSD projects heading into Phase 2.
Kurve CEO Marc Giroux said, “We are pleased that the DoD recognizes the value we bring to intranasally-challenging drug delivery. This is our third collaboration with the DoD, and we look forward taking it to fruition. We are currently involved in 17 nose-to-brain clinical studies, and with this one we expect to be dosing by mid-summer.”
Read the Kurve Technologies press release.
